---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-25-000003"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:28:28.947585+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health raises FY2025 non-GAAP EPS guidance to high end of $7.75-$7.90 range

## Summary
- Now expects FY2025 non-GAAP EPS toward high end of $7.75 to $7.90, driven by Pharmaceutical & Specialty Solutions strength.
- Previous guidance range was $7.75-$7.90; update reflects improved segment performance.
- Presenting at JP Morgan 43rd Annual Healthcare Conference on January 14, 2025.
- Further details on FY2025 expectations to be provided on Q2 earnings call January 30, 2025.

## SEC filing metadata
- accession: 0000721371-25-000003
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137125000003/0000721371-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000003/cah-20250114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-25-000003
- JSON: https://secwatch.observer/filing/0000721371-25-000003.json
- Plain text: https://secwatch.observer/filing/0000721371-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
